Biolase Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2024 to a ratio of 8.95, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2024. Average receivable collection period, for the Biolase Inc in Sep 30 2024 quarter, has decreased to 41 days, compared to 42 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 125 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 583 to 1345.

What is Receivable Turnover Ratio?
What is Biolase Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIOL Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	-19.55 %	-15.31 %	10.26 %	-6.13 %	-9.45 %
Y / Y Revenue Change	-3.39 %	-24.85 %	-10.81 %	-4.68 %	-10.52 %
Receivable Turnover Ratio (TTM)	8.95	8.64	8.95	9.39	9.36
BIOL's Total Ranking	# 1345	# 583	# 1331	# 1336	# 653
Accounts Receivable average collection period days	41	42	41	39	39
Seq. Receivable Change	-27.1 %	-14.86 %	3.72 %	24.95 %	-23.25 %
Seq. Revenue Change	-2.14 %	13.64 %	-30.29 %	24.63 %	-23.88 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 37
Healthcare Sector	# 126
Overall Market	# 1345

Receivable Turnover Ratio Statistics
High	Average	Low
10.48	6.33	3.91
(Dec 31 2021)		(Dec 31 2019)

BIOL Company Profile • Back to BIOL Efficiency Comparisons • Compare BIOL Receivables Turnover Ratio to its Competitors

Financial Statements
Biolase Inc 's Accounts Receivable	$ 4 Millions	Visit BIOL's Balance sheet
Biolase Inc 's Sales TTM	$ 44 Millions	Visit BIOL's Income Statement
Sources of BIOL's Revenues		Visit BIOL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BIOL's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BIOL's Growth Rates	BIOL's Roa	BIOL's Inventory Turnover Ratio	BIOL's Dividend Comparisons
BIOL's Profitability Ratios	BIOL's Roi	BIOL's Asset Turnover Ratio	BIOL's Dividend Growth
BIOL's Valuation Ratios	BIOL's Roe	BIOL's Financial Strength Ratios	BIOL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Ontrak Inc	34.00	$ 10.336 Millions	$ 0.304 Millions
Vivos Therapeutics Inc	33.86	$ 13.340 Millions	$ 0.394 Millions
Xoma Royalty Corporation	33.52	$ 21.606 Millions	$ 0.645 Millions
23andme Holding Co	33.34	$ 191.889 Millions	$ 5.756 Millions
Eyepoint Inc	32.81	$ 45.713 Millions	$ 1.393 Millions
Clearside Biomedical Inc	32.16	$ 7.703 Millions	$ 0.240 Millions
Spero Therapeutics Inc	30.43	$ 106.456 Millions	$ 3.498 Millions
Invo Fertility Inc	29.95	$ 6.228 Millions	$ 0.208 Millions
Cv Sciences Inc	29.75	$ 14.867 Millions	$ 0.500 Millions
Orchestra Biomed Holdings Inc	29.33	$ 2.647 Millions	$ 0.090 Millions
National Vision Holdings Inc	29.03	$ 1,952.174 Millions	$ 67.248 Millions
Sonida Senior Living Inc	27.68	$ 278.115 Millions	$ 10.046 Millions
Renalytix Plc	27.67	$ 2.352 Millions	$ 0.085 Millions
Neuraxis Inc	27.03	$ 2.456 Millions	$ 0.091 Millions
Marpai Inc	26.21	$ 30.093 Millions	$ 1.148 Millions
Adaptimmune Therapeutics Plc	25.59	$ 175.041 Millions	$ 6.841 Millions
Recursion Pharmaceuticals Inc	24.89	$ 65.184 Millions	$ 2.619 Millions
Lineage Cell Therapeutics Inc	23.85	$ 8.719 Millions	$ 0.366 Millions
Agenus Inc	23.56	$ 160.428 Millions	$ 6.810 Millions
Kymera Therapeutics Inc	23.35	$ 87.563 Millions	$ 3.750 Millions
Editas Medicine Inc	22.87	$ 61.758 Millions	$ 2.701 Millions
U S Physical Therapy Inc	22.39	$ 645.699 Millions	$ 28.841 Millions
Bespoke Extracts Inc	22.31	$ 1.080 Millions	$ 0.048 Millions
Cytomx Therapeutics Inc	22.28	$ 126.617 Millions	$ 5.684 Millions
One World Products Inc	22.21	$ 0.003 Millions	$ 0.000 Millions
Innovative Eyewear Inc	21.65	$ 1.562 Millions	$ 0.072 Millions
Ginkgo Bioworks Holdings Inc	21.39	$ 217.951 Millions	$ 10.188 Millions
Ethema Health Corporation	21.31	$ 5.675 Millions	$ 0.266 Millions
Co diagnostics Inc	19.94	$ 7.321 Millions	$ 0.367 Millions
Nutriband Inc	19.66	$ 2.022 Millions	$ 0.103 Millions

Date modified: 2026-08-29T17:19:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.